Target intelligence / Profile preview

Opsonin receptors

Molecular classification
Receptor, Cell surface protein, Immunoglobulin superfamily, Integrin
01

Overview

Opsonin receptors are a functional class of leukocyte surface proteins that recognize and bind to opsonins, which are host-derived molecules like antibodies (IgG) and complement fragments (C3b, iC3b) that coat pathogens or apoptotic cells. This group primarily includes Fc receptors (FcRs) and complement receptors (CRs), such as CR1, CR3 (Mac-1), and CR4, which are expressed on neutrophils, macrophages, and other myeloid cells. Upon ligation with opsonized targets, these receptors initiate intracellular signaling cascades—often involving Src-family kinases and Syk—that lead to phagocytosis, the release of reactive oxygen species, and the secretion of inflammatory cytokines. They are essential for the clearance of infectious agents and the maintenance of immune homeostasis, but their dysregulation is a key driver in autoimmune diseases and chronic inflammatory conditions. Therapeutic modulation of these receptors includes the use of intravenous immunoglobulin (IVIG) to block Fc receptors or monoclonal antibodies designed to enhance or inhibit opsonin-mediated cell clearance in cancer and inflammatory disorders.

Other names
Fc receptorsComplement receptorsPhagocytic receptorsOpsonin-binding receptors
02

Biological functions

PhagocytosisImmune responseCell activationSignal transductionRespiratory burstDegranulation
03

Disease associations

InflammationAutoimmune diseaseInfectionCancerSystemic lupus erythematosusRheumatoid arthritis
04

Safety considerations

Cytokine release syndromeImmunosuppressionInfusion-related reactionsAutoimmunity risk due to immune complex clearance defects
05

Interacting drugs

Intravenous immunoglobulin (IVIG)

5 more in the full profile.

06

Biomarkers

CD11b expressionFc gamma receptor polymorphisms (e.g., FCGR3A-V158F)C3b/iC3b deposition levelsSoluble Fc receptor levels

Beyond the preview

Go deeper on Opsonin receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opsonin receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call